Watermark
  Back to Search Results

BGB-11417-303

Recruiting

A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)

Ask to Join

BeOne Study ID Info icon SVG graphic used for tooltips or additional information.

BGB-11417-303

ClinicalTrials.gov ID Info icon SVG graphic used for tooltips or additional information.

NCT06943872

EudraCT Number Info icon SVG graphic used for tooltips or additional information.

2024-517131-52-00

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

No Study Documents

Locations

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

No Study Documents